- $75.77m
- $156.36m
- $2.02m
- 48
- 16
- 69
- 40
Annual income statement for CONX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 2.02 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 0.162 | 0.555 | 0.889 | 1.18 | 5.79 |
| Operating Profit | -0.162 | -0.555 | -0.889 | -1.18 | -3.77 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.12 | 19.4 | 25.4 | -5.93 | 2.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.12 | 19.4 | 24.2 | -5.99 | 2.67 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.12 | 19.4 | 24.2 | -5.99 | 2.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.12 | 19.4 | 24.2 | -5.99 | 2.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.023 | 0.206 | 0.292 | -0.252 | 0.086 |
| Dividends per Share |